Abstract:The emergence of the aggregation-induced emission (AIE) concept significantly changes the cognition of the scientific community toward classic photophysical phenomena. More importantly, the AIE phenomenon has brought huge opportunities for the analysis of bioactive species, the monitoring of complicated biological processes, and the elucidation of key physiological and pathological behaviors. As a class of promising luminescent materials, AIE luminogens (AIEgens) are weakly or non-emissive in the form of isolated molecular species but emit particularly strong fluorescence in the aggregated and solid states. Motivated by the prominent advantages such as high brightness, large Stokes shift, excellent photostability, and good biocompatibility, AIEgen-based bioprobes have been widely explored in the field of biomedicine. This review aims to provide a systematic summary of the developmental history and an in-depth perspective of the current landscape of AIE in the biomedical field, with an emphasis on the discussions of major working principles. The milestones of the historical development of AIE in the biomedical field are first reviewed. A total of four major research directions are then extracted, including biomacromolecule sensing (at the molecular level), in vitro cell imaging (at the cellular level), in vivo imaging (at the animal level), and cancer theranostics (at the cellular and animal levels), together with clear-cut tables showing comprehensive cases for further study. Lastly, this review is concluded by the discussions of several perspectives on future directions. It is believed that AIEgen-based bioprobes will play vital roles in the exploration of mysterious life processes by integration with various cutting-edge modalities and techniques with an ultimate goal of addressing more healthcare issues.

Rational fabrication and biomedical application of biomolecule‐conjugated AIEgens through click reaction

Imaging: Conjugated Polymer Amplified Far‐Red/Near‐Infrared Fluorescence from Nanoparticles with Aggregation‐Induced Emission Characteristics for Targeted in Vivo Imaging (adv. Healthcare Mater. 3/2013)

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

Redox-responsive Fluorescent AIE Bioconjugate with Aggregation Enhanced Retention Features for Targeted Imaging Reinforcement and Selective Suppression of Cancer Cells

Fabrication of hybridized nanoparticles with aggregation-induced emission characteristics and application for cell imaging

Aggregation‐induced Emission Based Fluorogens for Mitochondria‐targeted Tumor Imaging and Theranostics

Target-triggering, signal-amplified chemo/bio-sensors based on aggregation-induced emission luminogens

Molecular Design and Biomedical Application of AIEgens with Photochemical Activity

Unity Makes Strength: How Aggregation‐Induced Emission Luminogens Advance the Biomedical Field

A New Approach to Developing Diagnostics and Therapeutics: Aggregation-induced Emission-Based Fluorescence Turn-on

Aggregation‐Induced Emission Luminogens with Photoresponsive Behaviors for Biomedical Applications

Biomedical Application of Aggregation-Induced Emission Luminogen-Based Fluorescent Sensors

Biomacromolecule-Functionalized AIEgens for Advanced Biomedical Studies.

Conjugated Polymers with Aggregation‐Induced Emission Characteristics for Fluorescence Imaging and Photodynamic Therapy

Rational Design of Ratiometric Aggregation-Induced Emission Luminogens for Biosensing and Bioimaging

Bioorthogonal Turn-On Probe Based on Aggregation-Induced Emission Characteristics for Cancer Cell Imaging and Ablation.

Practicable Applications of Aggregation‐Induced Emission with Biomedical Perspective

Near-Infrared-Emissive AIE Bioconjugates: Recent Advances and Perspectives

Recent advances in assembled AIEgens for image-guided anticancer therapy

Biomarker-activatable probes based on smart AIEgens for fluorescence and optoacoustic imaging

Aggregation-Induced Emission: A Trailblazing Journey to the Field of Biomedicine